Skip to main content
Advertisement
  • Neurology.org
  • Journals
    • Neurology
    • Clinical Practice
    • Education
    • Genetics
    • Neuroimmunology & Neuroinflammation
  • Online Sections
    • Neurology Video Journal Club
    • Diversity, Equity, & Inclusion (DEI)
    • Innovations in Care Delivery
    • Practice Buzz
    • Practice Current
    • Residents & Fellows
    • Without Borders
  • Collections
    • COVID-19
    • Disputes & Debates
    • Health Disparities
    • Infographics
    • Neurology Future Forecasting Series
    • Null Hypothesis
    • Patient Pages
    • Topics A-Z
    • Translations
  • Podcast
  • CME
  • About
    • About the Journals
    • Contact Us
    • Editorial Board
  • Authors
    • Submit New Manuscript
    • Submit Revised Manuscript
    • Author Center

Advanced Search

Main menu

  • Neurology.org
  • Journals
    • Neurology
    • Clinical Practice
    • Education
    • Genetics
    • Neuroimmunology & Neuroinflammation
  • Online Sections
    • Neurology Video Journal Club
    • Diversity, Equity, & Inclusion (DEI)
    • Innovations in Care Delivery
    • Practice Buzz
    • Practice Current
    • Residents & Fellows
    • Without Borders
  • Collections
    • COVID-19
    • Disputes & Debates
    • Health Disparities
    • Infographics
    • Neurology Future Forecasting Series
    • Null Hypothesis
    • Patient Pages
    • Topics A-Z
    • Translations
  • Podcast
  • CME
  • About
    • About the Journals
    • Contact Us
    • Editorial Board
  • Authors
    • Submit New Manuscript
    • Submit Revised Manuscript
    • Author Center
  • Home
  • Latest Articles
  • Current Issue
  • Past Issues
  • Neurology Video Journal Club
  • Residents & Fellows

User menu

  • Subscribe
  • My Alerts
  • Log in

Search

  • Advanced search
Neurology
Home
The most widely read and highly cited peer-reviewed neurology journal
  • Subscribe
  • My Alerts
  • Log in
Site Logo
  • Home
  • Latest Articles
  • Current Issue
  • Past Issues
  • Neurology Video Journal Club
  • Residents & Fellows

Share

August 16, 2011; 77 (7) Clinical Implications of Neuroscience Research

Glycine and its synaptic interactions

Functional and clinical implications

Eduardo E. Benarroch
First published August 15, 2011, DOI: https://doi.org/10.1212/WNL.0b013e31822a2791
Eduardo E. Benarroch
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Full PDF
Citation
Glycine and its synaptic interactions
Functional and clinical implications
Eduardo E. Benarroch
Neurology Aug 2011, 77 (7) 677-683; DOI: 10.1212/WNL.0b013e31822a2791

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Permissions

Make Comment

See Comments

Downloads
1387

Share

  • Article
  • Figures & Data
  • Info & Disclosures
Loading

This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.

GLOSSARY

Cys=
cysteine;
GABA=
γ-aminobutyric acid;
GlyR=
glycine receptor;
KCC2=
K+, Cl− cotransporter 2;
NKH=
nonketotic hyperglycinemia;
NMDAR=
NMDA receptor;
VGAT=
vesicular GABA transporter;
VIAAT=
vesicular inhibitory amino acid transporter.

Glycine is a major neurotransmitter of inhibitory neurons in the spinal cord and brainstem. In many of these neurons, glycine coexists with γ-aminobutyric acid (GABA). The synaptic availability of glycine is controlled by 2 different transporters, and its postsynaptic effects are mediated by a specific chloride (Cl−) channel receptor. In the adult nervous system, glycine exerts fast postsynaptic inhibition that is important for control of excitability of motor neurons, auditory processing, pain transmission in the dorsal horn, and other functions. Corelease of GABA may affect the temporal profile of the postsynaptic effects of glycine. Glycine is also a coagonist of glutamate on NMDA receptors (NMDARs). Studies in vitro and in knockout mouse models have provided insight on the complex synaptic interactions among glycine, GABA, and glutamate, and on the consequences of impaired regulation of glycinergic transmission in the nervous system. Excessive synaptic levels of glycine may explain the manifestations of nonketotic hyperglycinemia, whereas loss-of-function mutations impairing glycinergic signaling have been linked to familial hyperekplexia. Autoimmune disorders affecting the glycine receptor (GlyR) complex may also result in excessive motoneuron excitability. Pharmacologic blockade of a glycine transporter may constitute a novel approach to increase NMDAR activity in schizophrenia. Many of these topics have been recently reviewed.1,–,9

GLYCINE AS A NEUROTRANSMITTER: VESICULAR STORAGE AND TRANSPORT MECHANISM

Synthesis and storage.

Glycine is the primary neurotransmitter of many inhibitory interneurons in the spinal cord and brainstem, including the ventral horn and motor cranial nerve nuclei, dorsal horn and trigeminal nuclei, and auditory and vestibular systems; it also mediates inhibitory effects of some amacrine cells and Golgi cells of the cerebellum.1 Glycine also has an essential role in intermediate metabolism; for example, it is the precursor to the one-carbon pool of folic acid intermediates that are fundamental to many synthetic reactions. Glycine is catabolized via the glycine cleavage system, a group …

View Full Text

AAN Members

We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.

Google Safari Microsoft Edge Firefox

Click here to login

AAN Non-Member Subscribers

Click here to login

Purchase access

For assistance, please contact:
AAN Members (800) 879-1960 or (612) 928-6000 (International)
Non-AAN Member subscribers (800) 638-3030 or (301) 223-2300 option 3, select 1 (international)

Sign Up
Information on how to subscribe to Neurology and Neurology: Clinical Practice can be found here 

Purchase
Individual access to articles is available through the Add to Cart option on the article page.  Access for 1 day (from the computer you are currently using) is US$ 39.00.  Pay-per-view content is for the use of the payee only, and content may not be further distributed by print or electronic means.  The payee may view, download, and/or print the article for his/her personal, scholarly, research, and educational use.  Distributing copies (electronic or otherwise) of the article is not allowed.

Letters: Rapid online correspondence

No comments have been published for this article.
Comment

REQUIREMENTS

If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org

Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.

Submission specifications:

  • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
  • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
  • Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
  • Article
    • GLOSSARY
    • GLYCINE AS A NEUROTRANSMITTER: VESICULAR STORAGE AND TRANSPORT MECHANISM
    • GLYCINE RECEPTORS
    • GLYCINE AND GABA AS COTRANSMITTERS IN INHIBITORY NEURONS
    • SYNAPTIC CROSSTALK BETWEEN GLYCINE AND GLUTAMATE
    • CLINICAL CORRELATIONS
    • PERSPECTIVE
    • Footnotes
    • REFERENCES
  • Figures & Data
  • Info & Disclosures
Advertisement

SARS-CoV-2 Vaccination Safety in Guillain-Barré Syndrome, Chronic Inflammatory Demyelinating Polyneuropathy, and Multifocal Motor Neuropathy

Dr. Jeffrey Allen and Dr. Nicholas Purcell

► Watch

Alert Me

  • Alert me when eletters are published

Recommended articles

  • Clinical Implications of Neuroscience Research
    Dorsal horn circuitry
    Complexity and implications for mechanisms of neuropathic pain
    Eduardo E. Benarroch et al.
    Neurology, February 17, 2016
  • Clinical Implications of Neuroscience Research
    Cation-chloride cotransporters in the nervous system
    General features and clinical correlations
    Eduardo E. Benarroch et al.
    Neurology, February 18, 2013
  • Article
    Novel clinical features of glycine receptor antibody syndrome
    A series of 17 cases
    Amanda L. Piquet, Murtaza Khan, Judith E.A. Warner et al.
    Neurology: Neuroimmunology & Neuroinflammation, July 01, 2019
  • ARTICLES
    Involvement of glycine and GABAA receptors in the pathogenesis of spinal myoclonus
    In vitro studies in the isolated neonatal rodent spinal cord
    Ely S. Simon et al.
    Neurology, October 01, 1995
Neurology: 100 (12)

Articles

  • Ahead of Print
  • Current Issue
  • Past Issues
  • Popular Articles
  • Translations

About

  • About the Journals
  • Ethics Policies
  • Editors & Editorial Board
  • Contact Us
  • Advertise

Submit

  • Author Center
  • Submit a Manuscript
  • Information for Reviewers
  • AAN Guidelines
  • Permissions

Subscribers

  • Subscribe
  • Activate a Subscription
  • Sign up for eAlerts
  • RSS Feed
Site Logo
  • Visit neurology Template on Facebook
  • Follow neurology Template on Twitter
  • Visit Neurology on YouTube
  • Neurology
  • Neurology: Clinical Practice
  • Neurology: Education
  • Neurology: Genetics
  • Neurology: Neuroimmunology & Neuroinflammation
  • AAN.com
  • AANnews
  • Continuum
  • Brain & Life
  • Neurology Today

Wolters Kluwer Logo

Neurology | Print ISSN:0028-3878
Online ISSN:1526-632X

© 2023 American Academy of Neurology

  • Privacy Policy
  • Feedback
  • Advertise